Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment.
Watanabe S, Ogasawara N, Kobayashi S, Kirino S, Inoue M, Hiraguri Y, Nagata S, Shimizu H, Ito G, Mizutani T, Nemoto Y, Tsuchiya K, Okamoto R, Watanabe M, Yui S. Watanabe S, et al. Among authors: kirino s. J Gastroenterol. 2023 Apr;58(4):379-393. doi: 10.1007/s00535-023-01959-y. Epub 2023 Feb 6. J Gastroenterol. 2023. PMID: 36745238
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate.
Kaneko S, Kurosaki M, Tamaki N, Itakura J, Hayashi T, Kirino S, Osawa L, Watakabe K, Okada M, Wang W, Shimizu T, Higuchi M, Takaura K, Yasui Y, Tsuchiya K, Nakanishi H, Takahashi Y, Watanabe M, Izumi N. Kaneko S, et al. Among authors: kirino s. J Gastroenterol Hepatol. 2019 Nov;34(11):2004-2010. doi: 10.1111/jgh.14686. Epub 2019 May 21. J Gastroenterol Hepatol. 2019. PMID: 31017689
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis.
Inada K, Kaneko S, Kurosaki M, Yamashita K, Kirino S, Osawa L, Hayakawa Y, Sekiguchi S, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Itakura J, Takahashi Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N. Inada K, et al. Among authors: kirino s. JGH Open. 2021 Aug 19;5(9):1085-1091. doi: 10.1002/jgh3.12636. eCollection 2021 Sep. JGH Open. 2021. PMID: 34584979 Free PMC article.
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice.
Hayakawa Y, Tsuchiya K, Kurosaki M, Yasui Y, Kaneko S, Tanaka Y, Ishido S, Inada K, Kirino S, Yamashita K, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Okamoto R, Izumi N. Hayakawa Y, et al. Among authors: kirino s. Invest New Drugs. 2022 Apr;40(2):392-402. doi: 10.1007/s10637-021-01185-4. Epub 2021 Sep 29. Invest New Drugs. 2022. PMID: 34586531
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy.
Sekiguchi S, Tsuchiya K, Yasui Y, Inada K, Kirino S, Yamashita K, Hayakawa Y, Osawa L, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Okamoto R, Kurosaki M, Izumi N. Sekiguchi S, et al. Among authors: kirino s. Cancer Rep (Hoboken). 2022 Nov;5(11):e1613. doi: 10.1002/cnr2.1613. Epub 2022 Mar 18. Cancer Rep (Hoboken). 2022. PMID: 35302279 Free PMC article.
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
Hayakawa Y, Tamaki N, Nakanishi H, Kurosaki M, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Takahashi Y, Tsuchiya K, Okamoto R, Izumi N. Hayakawa Y, et al. Among authors: kirino s. Intern Med. 2023 Apr 1;62(7):973-978. doi: 10.2169/internalmedicine.0212-22. Epub 2022 Sep 6. Intern Med. 2023. PMID: 36070941 Free PMC article.
Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B.
Kirino S, Tamaki N, Kurosaki M, Kaneko S, Inada K, Tanaka Y, Ishido S, Yamashita K, Nobusawa T, Matsumoto H, Hayakawa Y, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N. Kirino S, et al. Hepatol Res. 2023 Jan;53(1):35-42. doi: 10.1111/hepr.13839. Epub 2022 Oct 4. Hepatol Res. 2023. PMID: 36117296
Collagen type I-mediated mechanotransduction controls epithelial cell fate conversion during intestinal inflammation.
Kobayashi S, Ogasawara N, Watanabe S, Yoneyama Y, Kirino S, Hiraguri Y, Inoue M, Nagata S, Okamoto-Uchida Y, Kofuji S, Shimizu H, Ito G, Mizutani T, Yamauchi S, Kinugasa Y, Kano Y, Nemoto Y, Watanabe M, Tsuchiya K, Nishina H, Okamoto R, Yui S. Kobayashi S, et al. Among authors: kirino s. Inflamm Regen. 2022 Nov 28;42(1):49. doi: 10.1186/s41232-022-00237-3. Inflamm Regen. 2022. PMID: 36443773 Free PMC article.
Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population.
Kirino S, Tamaki N, Kurosaki M, Takahashi Y, Higuchi M, Itakura Y, Tanaka Y, Inada K, Ishido S, Yamashita K, Nobusawa T, Matsumoto H, Hayakawa Y, Kakegawa T, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N. Kirino S, et al. Quant Imaging Med Surg. 2023 Oct 1;13(10):6493-6502. doi: 10.21037/qims-23-511. Epub 2023 Aug 28. Quant Imaging Med Surg. 2023. PMID: 37869309 Free PMC article.
Discovery of non-genomic drivers of YAP signaling modulating the cell plasticity in CRC tumor lines.
Ogasawara N, Kano Y, Yoneyama Y, Kobayashi S, Watanabe S, Kirino S, Velez-Bravo FD, Hong Y, Ostapiuk A, Lutsik P, Onishi I, Yamauchi S, Hiraguri Y, Ito G, Kinugasa Y, Ohashi K, Watanabe M, Okamoto R, Tejpar S, Yui S. Ogasawara N, et al. Among authors: kirino s. iScience. 2024 Feb 16;27(3):109247. doi: 10.1016/j.isci.2024.109247. eCollection 2024 Mar 15. iScience. 2024. PMID: 38439969 Free PMC article.
59 results